UNSPSC 51434102: Chlorisondamine

This classification denotes a nicotinic antagonist with the molecular formula C14H20Cl4N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JD3M24F66I, chemically known as 1h-isoindolium, 4,5,6,7-tetrachloro-2,3-dihydro-2-methyl-2-(2- (trimethylammonio)ethyl)- but generally known as chlorisondamine, which bears US NIH Compound Identifier 6243. European Medicines Agency schedules Chlorisondamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06182MIG.

The term CHLORISONDAMINE is an International Non-Proprietary Name. As of Q4 2014, CHLORISONDAMINE remains the US FDA Preferred Term for this commodity. Chlorisondamine bears US NLM identifiers UMLS ID C0008211 and NCI Concept Code C83619. SMILES: C[N+]1(CC2=C(C1)C(=C(C(=C2Cl)Cl)Cl)Cl)CC[N+](C)(C)C.[Cl-].

UNSPSC 51434102 Chlorisondamine, a Commodity code, represents pharmaceutical supply contracts for state and local government agencies, particularly emergency medical services and health benefit programs. State and local procurement under this code focuses on bulk medication procurement for emergency responders and pharmacy benefit programs, with vendors supplying pharmaceutical products through authorized distribution channels under firm-fixed pricing with supply guarantees and shelf-life maintenance requirements. Issuing bodies include municipal fire rescue departments, state health and human services commissions, and multi-state cooperative purchasing alliances that source medications on behalf of participating state and local government facilities. The scope of work encompasses supplying specified medication line items with documented expiration dates, managing product replacement for expired stock, arranging rapid delivery on demand, and maintaining comprehensive compliance with FDA, OSHA, cGMP, and federal accessibility standards.

Recent activity spans Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department issued Bid No. 26P00188 on April 24, 2026, soliciting Advanced Life Support Medications for Tampa Fire Rescue with an estimated contract value of $40,000 and a response deadline of April 8, 2026; the solicitation specified four medication line items including Labetalol, Epinephrine, Adenosine, and Diltiazem, with a Small Local Business Enterprise sheltered market designation offering a 5 percent bid discount. The Texas Health and Human Services Commission posted Request for Information No. HHS0017013 on April 3, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program with no award value disclosed at this preliminary information-gathering stage. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026, for Generic Multi Source Pharmaceuticals and OTC Products with a March 26, 2026 response deadline; vendors must maintain relationships with three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), comply with 3 percent administrative fees and performance penalties ranging from $200 to $1,500 per violation, and demonstrate pricing flexibility across multiple formats, with contract term of two years.